Search
Aligos Therapeutics Inc
ALGSAdd to Watchlist
5.240USD
+0.070+1.35%
Close 09-18 16:00（ET）
32.31MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.35%
5 Days
+0.38%
1 Month
-22.49%
6 Months
-24.60%
Year to Date
-43.78%
1 Year
-47.55%
Key Figures
5.150Open
5.250High
650.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
5.170Prev. Close
5.015Low
3.36KTurnover
LossP/E Static
1.01P/B
0.00%Div Yield TTM
-83.92%ROA
13.68952wk High
0.02Volume Ratio
-131.21MNet Profit
6.24MShares
-9.7866EPS TTM
2.26Beta
-121.86%ROE
3.98052wk Low
1.93%Amplitude
100.00%Gross Margin
32.31MMarket Cap
5.21Reward/Risk
5.68%Risk Rate
Aligos Therapeutics Inc's Score
0.19vs previous score
Forecast8.25
Financial Health9.02
Technical6.81
Valuation Dimensions9.27
Institutional Confidence5.00
Risk Assessment2.23
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Aligos Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.14/-1.07
Revenue / Forecast
27.78M/18.24M
Aligos Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolALGS
Number of employees70
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Deep Track Capital LP | 8.24% |
| Roche Holding AG | 8.19% |
| Alyeska Investment Group, L.P. | 7.65% |
| Sio Capital Management, LLC | 6.23% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 37.23% |
| Holding Company | 8.19% |
| Investment Advisor/Hedge Fund | 7.37% |
| Investment Advisor | 6.63% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Aligos Therapeutics Inc (ALGS)?
The current price of Aligos Therapeutics Inc (ALGS) is 5.24.
What is the symbol of Aligos Therapeutics Inc?
The ticker symbol of Aligos Therapeutics Inc is ALGS.
What is the 52-week high of Aligos Therapeutics Inc?
The 52-week high of Aligos Therapeutics Inc is 13.69.
What is the 52-week low of Aligos Therapeutics Inc?
The 52-week low of Aligos Therapeutics Inc is 3.98.
What is the market capitalization of Aligos Therapeutics Inc?
The market capitalization of Aligos Therapeutics Inc is 32.31M.
Is Aligos Therapeutics Inc (ALGS) currently rated as Buy, Hold, or Sell?
According to analysts, Aligos Therapeutics Inc (ALGS) has an overall rating of Buy, with a price target of 52.71.
What is the Earnings Per Share (EPS TTM) of Aligos Therapeutics Inc (ALGS)?
The Earnings Per Share (EPS TTM) of Aligos Therapeutics Inc (ALGS) is -9.79.